Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H8NOS.Au |
Molecular Weight | 363.187 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Au+].[S-]CC(=O)NC1=CC=CC=C1
InChI
InChIKey=ODENGJOFMCVWCT-UHFFFAOYSA-M
InChI=1S/C8H9NOS.Au/c10-8(6-11)9-7-4-2-1-3-5-7;/h1-5,11H,6H2,(H,9,10);/q;+1/p-1
Molecular Formula | Au |
Molecular Weight | 196.9666 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C8H9NOS |
Molecular Weight | 167.228 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Doses
Dose | Population | Adverse events |
---|---|---|
100 mg 1 times / week steady, intramuscular (max) Dose: 100 mg, 1 times / week Route: intramuscular Route: steady Dose: 100 mg, 1 times / week Sources: |
unhealthy, 52 years (range: 18-72 years) n = 56 Health Status: unhealthy Condition: rheumatoid arthritis Age Group: 52 years (range: 18-72 years) Sex: M+F Population Size: 56 Sources: |
Disc. AE: Thrombocytopenic purpura... AEs leading to discontinuation/dose reduction: Thrombocytopenic purpura (1 patient) Sources: |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Thrombocytopenic purpura | 1 patient Disc. AE |
100 mg 1 times / week steady, intramuscular (max) Dose: 100 mg, 1 times / week Route: intramuscular Route: steady Dose: 100 mg, 1 times / week Sources: |
unhealthy, 52 years (range: 18-72 years) n = 56 Health Status: unhealthy Condition: rheumatoid arthritis Age Group: 52 years (range: 18-72 years) Sex: M+F Population Size: 56 Sources: |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:23:23 GMT 2023
by
admin
on
Fri Dec 15 15:23:23 GMT 2023
|
Record UNII |
2A9D34A16M
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
10381
Created by
admin on Fri Dec 15 15:23:23 GMT 2023 , Edited by admin on Fri Dec 15 15:23:23 GMT 2023
|
PRIMARY | |||
|
100000086640
Created by
admin on Fri Dec 15 15:23:23 GMT 2023 , Edited by admin on Fri Dec 15 15:23:23 GMT 2023
|
PRIMARY | |||
|
186
Created by
admin on Fri Dec 15 15:23:23 GMT 2023 , Edited by admin on Fri Dec 15 15:23:23 GMT 2023
|
PRIMARY | |||
|
C166562
Created by
admin on Fri Dec 15 15:23:23 GMT 2023 , Edited by admin on Fri Dec 15 15:23:23 GMT 2023
|
PRIMARY | |||
|
2A9D34A16M
Created by
admin on Fri Dec 15 15:23:23 GMT 2023 , Edited by admin on Fri Dec 15 15:23:23 GMT 2023
|
PRIMARY | |||
|
16925-51-2
Created by
admin on Fri Dec 15 15:23:23 GMT 2023 , Edited by admin on Fri Dec 15 15:23:23 GMT 2023
|
PRIMARY | |||
|
m57
Created by
admin on Fri Dec 15 15:23:23 GMT 2023 , Edited by admin on Fri Dec 15 15:23:23 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID10168680
Created by
admin on Fri Dec 15 15:23:23 GMT 2023 , Edited by admin on Fri Dec 15 15:23:23 GMT 2023
|
PRIMARY | |||
|
SUB05611MIG
Created by
admin on Fri Dec 15 15:23:23 GMT 2023 , Edited by admin on Fri Dec 15 15:23:23 GMT 2023
|
PRIMARY |